Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neurochemistry

• Publication date

  2002-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.2002.00940.xPMID 12091468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue-Specific Proteolysis of Huntingtin (htt) in Human Brain: Evidence of Enhanced Levels of N- and C-Terminal htt Fragments in Huntington's Disease Striatum

  2001cited by this paper
• Mutant protein in Huntington disease is resistant to proteolysis in affected brain

  2001cited by this paper
• Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis

  2001cited by this paper
• Inhibiting Caspase Cleavage of Huntingtin Reduces Toxicity and Aggregate Formation in Neuronal and Nonneuronal Cells*

  2000cited by this paper
• Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

  2000cited by this paper
• Evidence for functional localization of the proenkephalin-processing enzyme, prohormone thiol protease, to secretory vesicles of chromaffin cells.

  1999cited by this paper
• Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization

  1999cited by this paper
• Molecular Studies Define the Primary Structure of α1-Antichymotrypsin (ACT) Protease Inhibitor in Alzheimer’s Disease Brains

  1999cited by this paper
• Recent advances on the pathogenesis of Huntington's disease.

  1999cited by this paper
• Transgenic models of Huntington's disease.

  1999cited by this paper
• Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation

  1999cited by this paper
• Mutant Huntingtin Expression in Clonal Striatal Cells: Dissociation of Inclusion Formation and Neuronal Survival by Caspase Inhibition

  1999cited by this paper
• The Kunitz Protease Inhibitor Form of the Amyloid Precursor Protein (KPI/APP) Inhibits the Proneuropeptide Processing Enzyme Prohormone Thiol Protease (PTP)

  1999cited by this paper
• A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

  1999cited by this paper
• Huntington disease.

  1998cited by this paper
• The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity

  1998cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions.

  1998cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997influential reference
• Energy metabolism defects in Huntington's disease and effects of coenzyme Q10

  1997cited by this paper
• Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

  1997cited by this paper
• Transgenic models of Huntington's disease.

  1997influential reference
• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

  1997cited by this paper
• Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease

  1996cited by this paper
• Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract

  1996cited by this paper
• Mitochondrial defect in Huntington's disease caudate nucleus

  1996cited by this paper
• Molecular cloning reveals isoforms of bovine alpha 1-antichymotrypsin.

  1994cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease

  1988cited by this paper
• Huntington's disease

  1984cited by this paper
• INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY

  1976cited by this paper

• Huntingtin, the Major Factor in Huntington’s Disease Development. Main Functions and Intracellular Proteolysis

  2024cites this paper
• HUNTINGTIN, THE MAIN FACTOR IN HUNTINGTON’S DISEASE DEVELOPMENT. MAIN FUNCTIONS AND INTRACELLULAR PROTEOLYSIS

  2024cites this paper
• Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington’s disease

  2022cites this paper
• Gradual Phenotype Development in Huntington Disease Transgenic Minipig Model at 24 Months of Age

  2018cites this paper
• Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates

  2017cites this paper
• Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.

  2017cites this paper
• Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo*

  2015cites this paper
• SUMO modulation of protein aggregation and degradation

  2015cites this paper
• Studying polyglutamine diseases in Drosophila.

  2015cites this paper
• From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease

  2014cites this paper
• Identification of novel alternative splicing events in the huntingtin gene and assessment of the functional consequences using structural protein homology modelling.

  2014cites this paper
• Myeloid cell function in Huntington's disease

  2013cites this paper
• Depletion of cognate charged transfer RNA causes translational frameshifting within the expanded CAG stretch in huntingtin.

  2013cites this paper
• Huntingtin: Here, There, Everywhere!

  2013cites this paper
• Effects of Chronic Oxidative Stress on TRPM2 and TRPC3 Channels: Potential Implications for Bipolar Disorder

  2013cites this paper
• Characterisation of huntingtin localisation and transcriptional regulation in response to growth factor stimulation in an immortalised cell model of Huntington's Disease

  2013cites this paper
• Native Mutant Huntingtin in Human Brain

  2012cites this paper
• Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway.

  2012cites this paper
• Assessing polyglutamine conformation in the nucleating event by molecular dynamics simulations.

  2012cites this paper
• Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.

  2012cites this paper
• Transgenic Animal Models of Huntington's Disease.

  2011cites this paper
• Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells

  2011cites this paper
• Molecular mechanisms and potential therapeutical targets in Huntington's disease.

  2010cites this paper
• The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review

  2009influential citation
• Huntington's disease: The current state of research with peripheral tissues

  2009cites this paper
• Aggregationsverhalten des Polyglutaminproteins Ataxin-3 in vitro und in Zellkultur

  2006cites this paper
• Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis.

  2006cites this paper
• Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington's disease mutation.

  2006cites this paper
• Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts.

  2005cites this paper
• Decreased cAMP Response Element-mediated Transcription

  2004cites this paper
• Subcellular analysis of aberrant protein structure in age-related neurodegenerative disorders.

  2004cites this paper
• Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis.

  2003cites this paper
• Role of proteolysis in polyglutamine disorders

  2003influential citation
• Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum.

  2003cites this paper
• Towards understanding the pathogenesis of polyglutamine disorders: mRNA and protein expression, proteolytic cleavage and proteasomal degradation

  2003cites this paper
• The use of transgenic and knock-in mice to study Huntington’s disease

  2003cites this paper
• Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.

  2002cites this paper